All News

A large cohort study shows that buprenorphine treatment during pregnancy significantly lowers the risk of preterm birth, severe maternal morbidity, and neonatal complications in women with opioid use disorder.

New research links combined oral contraceptives to changes in the gut microbiome that may contribute to mood disorders.

New guidelines on GSM recommends symptom-based diagnosis, shared decision-making, and local estrogen as first-line therapy to improve quality of life.

A new study found that prolonged time between waking and eating in pregnancy is associated with increased calorie consumption and disrupted sleep patterns.

A new study shows the Stanford Obstetric Recovery Checklist is a valid, reliable, and responsive tool for assessing outpatient postpartum recovery at multiple stages.

Limiting the number of fresh donor oocytes fertilized can reduce excess embryo creation while maintaining high live birth rates.

A new survey highlights major gaps in fertility knowledge, emphasizing the importance of anti-müllerian hormone testing, insurance coverage awareness, and early proactive care.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Despite abortion bans in several states, a new study showed no significant shift in where OBGYNs choose to practice.

Leeya Pinder, MD, MPH, highlights a national conference to spotlight the role of human papillomavirus in cancer, emphasizing vaccination, screening innovations, and collaborative efforts to eliminate cervical cancer.

The potential shutdown of the 30-year Women’s Health Initiative threatens critical research on aging, disease prevention, and postmenopausal women’s health.

A UK study links maternal anemia in early pregnancy with increased congenital heart disease risk in offspring.

New research reveals a significant link between urinary incontinence and increased cardiovascular disease risk, even without reduced physical activity.

A new University of Sydney study reveals a strong connection between poor oral health and higher rates of migraines, body pain, and abdominal pain in women.

A new study reveals a surge in firearm suicides among women, many with no prior mental health history.

A UK survey reveals growing recognition and interest in obesity medications such as semaglutide and tirzepatide, with women showing significantly higher awareness and understanding.

A new study reveals that while patient acceptance of artificial intelligence in breast cancer screening is growing, trust varies based on personal medical history and demographics.

Find out the top 5 latest updates and headlines in fertility research in honor of National Infertility Awareness Week (April 20-26, 2025).

A new study found that older women experiencing persistent or changing social isolation are at higher risk of unhealthy eating habits.

A new survey highlights gender differences in knowledge and attitudes toward GLP-1/GIP receptor agonists.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study finds that women who experience menopause before the age of 40 years face a higher risk of cognitive decline.

A new study found that routine mammography significantly reduces late-stage diagnoses and mortality in women aged 70 years and older.

Stephanie Pearson, MD, FACOG, shares her journey transitioning from a provider to a patient following a work-related accident.

A new study reveals that polycystic ovary syndrome patients with subclinical hypothyroidism face greater risks of hormonal and metabolic imbalances.

A new study found that cell-free DNA from routine prenatal testing can accurately identify preterm birth risk without added cost or procedures.

A new study links gestational diabetes and high blood pressure during pregnancy to higher long-term cardiovascular disease risk, especially among women with obesity.

A novel oral antibiotic, gepotidacin (Blujepa; GSK), has demonstrated its effectiveness in treating uncomplicated urogenital gonorrhea, according to the results of a recent phase 3 clinical trial.